Hedgehog Gli3 activator signal augments tumorigenicity of colorectal cancer via upregulation of adherence-related genes

Cancer Science

Volumn 104, Issue 3, 2013, Pages 328-336

  Iwasaki, Hironori ^a   Nakano, Kenji ^b   Shinkai, Kentaro ^a   Kunisawa, Yumi ^b   Hirahashi, Minako ^a   Oda, Yoshinao ^a   Onishi, Hideya ^a   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Innovation Center for Medical Redox Navigation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEDGEHOG GLI3 ACTIVATOR; PROTEIN P53; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENICITY; COLORECTAL CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE SILENCING; GENES, P53; HEDGEHOG PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, SCID; MUTATION; NEOPLASM TRANSPLANTATION; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84874453448     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12073     Document Type: Article

References (46)

1. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001; 15: 3059-87.
2. McMahon AP, Ingham PW, Tabin CJ. Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 2003; 53: 1-114.
3. Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Biol 2005; 6: 306-17.
4. di Magliano MP, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003; 3: 903-11.
5. Ruel L, Rodriguez R, Gallet A, Lavenant-Staccini L, Thérond PP. Stability and association of Smoothened, Costal2 and Fused with Cubitus interruptus are regulated by Hedgehog. Nat Cell Biol 2003; 5: 907-13.
6. Stecca B, Ruiz IAA. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J 2009; 28: 663-76.
7. Stecca B, Ruiz IAA. Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol 2010; 2: 84-95.
8. Wang B, Fallon JF, Beachy PA. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 2000; 100: 423-34.
9. Pan Y, Bai CB, Joyner AL, Wang B. Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol Cell Biol 2006; 26: 3365-77.
10. Wang Y, McMahon AP, Allen BL. Shifting paradigms in Hedgehog signaling. Curr Opin Cell Biol 2007; 19: 159-65.
11. Lee J, Platt KA, Censullo P, Ruiz IAA. Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 1997; 124: 2537-52.
12. Kinzler KW, Bigner SH, Bigner DD et al. Identification of an amplified, highly expressed gene in a human glioma. Science 1987; 236: 70-3.
13. Zurawel RH, Allen C, Chiappa S et al. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosom Cancer 2000; 27: 44-51.
14. Tostar U, Malm CJ, Meis-Kindblom JM, Kindblom LG, Toftgård R, Undén AB. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. J Pathol 2006; 208: 17-25.
15. Ma X, Chen K, Huang S et al. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 2005; 26: 1698-705.
16. Thayer SP, di Magliano MP, Heiser PW et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425: 851-6.
17. Kubo M, Nakamura M, Tasaki A et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 2004; 64: 6071-4.
18. Karhadkar SS, Bova GS, Abdallah N et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004; 431: 707-12.
19. Yoo YA, Kang MH, Lee HJ et al. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 2011; 71: 7061-70.
20. Nagai S, Nakamura M, Yanai K et al. Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation. Cancer Sci 2008; 99: 1377-84.
21. Souzaki M, Kubo M, Kai M et al. Hedgehog signaling pathway mediates the progression of non-invasive breast cancer to invasive breast cancer. Cancer Sci 2011; 102: 373-81.
22. Bar EE, Chaudhry A, Lin A et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 2007; 25: 2524-33.
23. Dierks C, Beigi R, Guo GR et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 2008; 14: 238-49.
24. Peacock CD, Wang Q, Gesell GS et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 2007; 104: 4048-53.
25. Zhao C, Chen A, Jamieson CH et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009; 458: 776-9.
26. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz IAA. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007; 17: 165-72.
27. Douard R, Moutereau S, Pernet P et al. Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer. Surgery 2006; 139: 665-70.
28. Akiyoshi T, Nakamura M, Koga K et al. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation. Gut 2006; 55: 991-9.
29. Litingtung Y, Dahn RD, Li Y, Fallon JF, Chiang C. Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity. Nature 2002; 418: 979-83.
30. Ding Q, Motoyama J, Gasca S et al. Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. Development 1998; 125: 2533-43.
31. Park HL, Bai C, Platt KA et al. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 2000; 127: 1593-605.
32. Kang HN, Oh SC, Kim JS, Yoo YA. Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53. Exp Cell Res 2012; 318: 539-49.
33. Notarnicola M, Cavallini A, Cardone R, Pezzolla F, Demma I, Di Leo A. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer. Dig Liver Dis 2000; 32: 131-6.
34. Ghavam-Nasiri MR, Rezaei E, Ghafarzadegan K, Seilanian-Toosi M, Malekifard H. Expression of p53 in colorectal carcinoma: correlation with clinicopathologic features. Arch Iran Med 2007; 10: 38-42.
35. Miyaki M, Iijima T, Yasuno M et al. High incidence of protein-truncating mutations of the p53 gene in liver metastases of colorectal carcinomas. Oncogene 2002; 21: 6689-93.
36. Onishi H, Kai M, Odate S et al. Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer. Cancer Sci 2011; 102: 1144-50.
37. Kameda C, Tanaka H, Yamasaki A et al. The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer. Anticancer Res 2009; 29: 871-79.
38. Gulino A, Ferretti E, De Smaele E. Hedgehog signalling in colon cancer and stem cells. EMBO Mol Med 2009; 1: 300-2.
39. Varnat F, Siegl-Cachedenier I, Malerba M, Gervaz P, Ruiz IAA. Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas. EMBO Mol Med 2010; 2: 440-57.
40. Qualtrough D, Buda A, Gaffield W, Williams AC, Paraskeva C. Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment. Int J Cancer 2004; 110: 831-7.
41. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001; 1: 55-67.
42. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-7.
43. Morin PJ, Vogelstein B, Kinzler KW. Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 1996; 93: 7950-4.
44. Barault L, Veyrie N, Jooste V et al. Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int J Cancer 2008; 122: 2255-9.
45. Benhattar J, Losi L, Chaubert P, Givel JC, Costa J. Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 1993; 104: 1044-8.
46. Wallin U, Glimelius B, Jirström K et al. Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer. Br J Cancer 2011; 104: 1619-27.